By Sabrina Valle and Michael Erman Aug 2 (Reuters) – AstraZeneca Plc and Bristol Myers Squibb held preliminary discussions about a possible combination that would create one of the world's biggest
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
BRIEF-Saba Capital Holds 16.4% Voting Rights In Syncona As Of Sept 21
Sept 23 (Reuters) - Syncona Ltd: * SABA CAPITAL HOLDS 16.4% VOTING RIGHTS IN SYNCONA…
UK media regulator investigates Pornhub over age checks
LONDON, Sept 23 (Reuters) - Britain's media regulator Ofcom said on Wednesday that it had…
Singapore's link to US stocks is struggling to attract traders
By Gregor Stuart Hunter SINGAPORE, Sept 23 (Reuters) - Singapore's effort to offer trading in…
